Skip to content
Clinical Trials – home

Eosinophilic oesophagitis Diagnostics

Clinical trials for Eosinophilic oesophagitis

Recruiting trials first

See all 11 trials →
Quick filters

11 clinical trials in this condition

Study on the Effects of EP-104IAR and Tetracosactide for Adults with Eosinophilic Esophagitis

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Tetracosactide
  • Sponsor:Eupraxia Pharmaceuticals Inc.

Study on BP1.7881 for Adults with Eosinophilic Esophagitis

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bp1.7881A
  • Sponsor:Bioprojet Pharma

Eosinophilic oesophagitis

Not yet recruiting

Dupilumab Maintenance Dose Optimization in Adults with Eosinophilic Esophagitis: A Randomized Controlled Non‑Inferiority Study

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Amsterdam UMC Stichting

Eosinophilic oesophagitis

Not yet recruiting

Study on the Use of Viscous Budesonide for Children with Eosinophilic Esophagitis

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Budesonide
  • Sponsor:University Hospital Consorziale Policlinico
See all 11 trials →filters applied: condition = Eosinophilic oesophagitis

In short

Diagnosing eosinophilic oesophagitis requires careful investigation by healthcare specialists, combining detailed clinical evaluation with specific laboratory tests. Understanding when to seek medical attention and what tests are necessary can help patients receive timely treatment and manage this chronic condition effectively.

Key points

  • The only definitive way to diagnose eosinophilic esophagitis is through upper endoscopy with tissue biopsies showing 15 or more eosinophils per high-power field
  • Your esophagus can look completely normal during endoscopy and you can still have eosinophilic esophagitis—visual appearance alone isn't enough for diagnosis
  • If heartburn doesn't improve with acid-reducing medications, you may need diagnostic testing for eosinophilic esophagitis rather than just more reflux treatment
  • People with other allergic conditions like asthma or eczema have a higher risk of developing eosinophilic esophagitis and should pay attention to swallowing symptoms
  • Blood tests and allergy tests can provide supporting information but cannot diagnose eosinophilic esophagitis by themselves
  • Multiple biopsies from different areas of the esophagus improve diagnostic accuracy because inflammation may not be uniform
  • Clinical trials for eosinophilic esophagitis typically require more frequent testing and endoscopies than standard care, providing close monitoring but requiring significant time commitment
  • Eosinophilic esophagitis was only recognized as a distinct disease in the 1990s, making it one of the newest identified chronic digestive conditions

Introduction: When to Seek Diagnostic Testing

If you experience ongoing difficulty swallowing, especially with solid foods like meat or bread, or if you have heartburn that doesn't improve with common acid-reducing medications, it may be time to talk to your doctor about testing for eosinophilic oesophagitis. This condition can affect people of all ages, from infants to older adults, and symptoms often vary depending on when the disease develops.

Many people live with symptoms for years before receiving an accurate diagnosis because the signs of eosinophilic oesophagitis can resemble other, more common digestive problems. Young children might refuse to eat, vomit frequently, or fail to gain weight properly. School-age children often complain of recurring stomach pain or have trouble swallowing. Adults typically notice that food gets stuck in the throat or chest, which can be frightening and uncomfortable.

You should consider diagnostic testing if you have experienced food getting stuck in your oesophagus, even once. This situation, called food impaction, can be a medical emergency because it may tear a hole in the oesophagus. Other warning signs include frequent vomiting, chest pain that doesn't respond to antacids, or heartburn that persists despite taking proton pump inhibitors or other acid suppressors.

People with other allergic conditions should be especially attentive to digestive symptoms. If you already have asthma, hay fever, eczema, or food allergies, your risk of developing eosinophilic oesophagitis is higher than in the general population. Having a family member with the condition also increases your likelihood of developing it, suggesting that genetics play some role.

Classic Diagnostic Methods

The diagnosis of eosinophilic oesophagitis requires a combination of clinical history, symptoms, and specific test results. No single blood test or simple examination can confirm the condition. Instead, doctors rely on a procedure called an upper endoscopy with tissue sampling to make the diagnosis.

Upper Endoscopy

An upper endoscopy, also called an esophagogastroduodenoscopy or EGD, is the essential procedure for diagnosing eosinophilic oesophagitis. During this examination, a doctor inserts a long, flexible tube equipped with a tiny camera and light through your mouth and down into your oesophagus. This tube, called an endoscope, allows the physician to see the inside of your oesophagus and look for signs of inflammation or damage.

During the endoscopy, your doctor examines the oesophageal lining for specific visual features. In many patients with eosinophilic oesophagitis, the oesophagus shows distinctive patterns. These can include white spots or patches on the lining, horizontal rings that give the oesophagus a corrugated appearance (sometimes described as looking like rings on a tree trunk), vertical furrows or grooves running lengthwise, narrowing of the oesophagus called strictures, and areas that tear easily or appear fragile.

However, it's important to know that some people with eosinophilic oesophagitis have an oesophagus that looks completely normal during the examination. The absence of visible changes doesn't rule out the condition. This is why taking tissue samples is absolutely necessary for diagnosis.

Oesophageal Biopsy

The definitive way to diagnose eosinophilic oesophagitis is through biopsy, which means taking small pieces of tissue from the oesophageal lining during the endoscopy. These tissue samples are typically very small, about the size of a pen tip. The doctor takes multiple samples from different areas of the oesophagus to ensure accurate results.

After the procedure, the tissue samples are sent to a laboratory where a specialist called a pathologist examines them under a microscope. The pathologist looks for an unusually high number of eosinophils, which are a type of white blood cell. In a healthy oesophagus, there should be no eosinophils present. In eosinophilic oesophagitis, the pathologist will find 15 or more eosinophils when viewing the tissue through the microscope at high magnification (per high-power field).

Finding this elevated number of eosinophils in the oesophageal tissue, combined with symptoms of oesophageal dysfunction, confirms the diagnosis. The biopsy results are essential because eosinophils in the oesophagus can appear in other conditions too, such as acid reflux disease, certain infections, or other inflammatory disorders. Your doctor needs to rule out these other possibilities before confirming eosinophilic oesophagitis.

Distinguishing from Other Conditions

Because several conditions can cause similar symptoms or show eosinophils in oesophageal tissue, your doctor must carefully distinguish eosinophilic oesophagitis from other diseases. One of the most common conditions that must be ruled out is gastroesophageal reflux disease (GERD), where stomach acid flows back into the oesophagus and causes irritation. GERD is much more common than eosinophilic oesophagitis and can sometimes also show eosinophils in the oesophagus, though usually in smaller numbers.

Other conditions that doctors consider include infections of the oesophagus (from fungi, viruses, or bacteria), celiac disease (an immune reaction to gluten that can affect the digestive system), inflammatory bowel diseases like Crohn's disease, and a rare condition called hypereosinophilic syndrome where eosinophils are elevated throughout the body, not just in the oesophagus.

Additional Testing

Beyond the endoscopy and biopsy, your doctor may order additional tests to better understand your condition and identify possible triggers. Blood tests can measure your total number of eosinophils in the bloodstream and check levels of immunoglobulin E (IgE), a substance the immune system produces during allergic reactions. High levels of either can suggest that allergies are playing a role in your condition.

Some doctors may recommend allergy testing to identify specific foods or environmental substances that might be triggering the inflammation in your oesophagus. This can be done through blood tests or skin tests. However, the relationship between allergy test results and eosinophilic oesophagitis is complex. Having positive allergy tests doesn't necessarily mean those specific allergens are causing your oesophageal inflammation, and you might react to foods that don't show up on allergy tests.

A newer diagnostic approach called an oesophageal sponge test is being studied in some medical centers. This involves swallowing a capsule attached to a string. The capsule dissolves in your stomach, releasing a small sponge that is then pulled back up through the oesophagus by the string. As it travels upward, the sponge collects cells from the oesophageal lining, which can then be examined for eosinophils. This test can be performed in a doctor's office without the need for sedation, potentially making monitoring easier and less invasive. However, it is not yet widely available.

Diagnostics for Clinical Trial Qualification

When researchers conduct clinical trials to test new treatments for eosinophilic oesophagitis, they use specific diagnostic criteria to determine which patients can participate. These criteria are often more detailed and standardized than what might be used in regular clinical practice, ensuring that all study participants have similar characteristics and disease severity.

The cornerstone of clinical trial enrollment is confirming the diagnosis through upper endoscopy with multiple biopsies showing the characteristic number of eosinophils. Most clinical trials require patients to have at least 15 eosinophils per high-power field in at least one biopsy sample from the oesophagus. Some studies may require evidence from multiple areas of the oesophagus or a certain average count across all samples taken.

Patients must also have documented symptoms of oesophageal dysfunction. For adults and teenagers, this typically means difficulty swallowing solid foods, food impaction episodes, or chest pain when eating. For younger children, qualifying symptoms might include vomiting, poor appetite, failure to gain weight appropriately, or feeding difficulties. The severity and frequency of these symptoms are often measured using standardized questionnaires that patients or parents complete.

Clinical trials usually require that other conditions causing oesophageal eosinophilia have been ruled out. This means participants must undergo testing to exclude infections, celiac disease, inflammatory bowel disease, and other disorders that could explain their symptoms and biopsy findings. Sometimes this involves additional blood tests, biopsies from other parts of the digestive system, or specific diagnostic procedures.

Many trials examine how well patients respond to stopping certain medications before enrolling them. For example, some studies require that participants have continued to show eosinophilic inflammation despite taking proton pump inhibitors for a specified period, often eight weeks or longer. This helps ensure that the inflammation isn't simply due to acid reflux that could be managed with standard treatments.

Researchers often use endoscopy to assess not just the microscopic appearance of tissue but also the visible features of the oesophagus. They may document the presence and severity of rings, furrows, white patches, strictures, or other abnormalities using standardized scoring systems. These visual features help researchers categorize patients by disease severity and track whether treatments lead to healing of the oesophageal lining.

Before and during clinical trials, participants typically undergo repeat endoscopies at specified intervals to monitor how their oesophageal inflammation responds to the treatment being studied. These procedures, performed at baseline (before treatment starts) and at predetermined times during and after treatment, allow researchers to measure objective changes in eosinophil counts and oesophageal appearance, not just rely on patients' reports of symptom improvement.

Some clinical trials also collect additional research samples during diagnostic procedures. This might include extra tissue biopsies for genetic analysis, measurements of immune system molecules in the oesophageal tissue, or samples to study the types of bacteria and other microorganisms living in the oesophagus. These research specimens help scientists better understand what causes eosinophilic oesophagitis and how treatments work.

Quality of life assessments are another important component of clinical trial diagnostics. Researchers use validated questionnaires to measure how the disease affects patients' daily activities, emotional well-being, and social functioning. These assessments help determine whether new treatments not only reduce inflammation and symptoms but also improve patients' overall experience of living with the condition.

Prognosis and Survival Rate

Prognosis

Eosinophilic oesophagitis is a chronic condition that requires ongoing management, but it does not appear to limit life expectancy. There is currently no strong evidence suggesting that the condition causes cancer of the oesophagus, which is an important reassurance for patients concerned about long-term outcomes.

The progression of the disease varies from person to person. Without treatment, eosinophilic oesophagitis tends to cause ongoing inflammation in the oesophagus, which over time can lead to scarring and structural changes. These changes may result in narrowing of the oesophagus (strictures), making swallowing increasingly difficult and raising the risk of food becoming stuck.

With appropriate treatment, many patients can achieve and maintain remission, meaning their symptoms improve significantly and the inflammation in their oesophagus decreases. However, eosinophilic oesophagitis is not typically "cured" or outgrown. Most people require long-term treatment to keep the condition under control and prevent complications. Some patients experience periods when symptoms worsen (called flare-ups) alternating with times when symptoms are minimal or absent.

Factors that may affect prognosis include how long someone has had untreated disease before diagnosis (longer delays may allow more scarring to develop), how well they respond to initial treatments, whether they can identify and avoid food triggers, and how consistently they follow their treatment plan. Early diagnosis and treatment appear to help prevent some of the long-term complications, particularly the development of strictures that make swallowing difficult.

Survival rate

Because eosinophilic oesophagitis is not a life-threatening disease, survival rates are not typically reported in the medical literature. The condition itself does not cause death. While complications such as severe food impaction can be medical emergencies requiring prompt treatment, these situations are manageable with appropriate medical care, and serious outcomes are rare.

The primary concern with eosinophilic oesophagitis is not mortality but rather quality of life. The condition can significantly affect how people eat, their social interactions around meals, their nutritional status, and their emotional well-being. Proper diagnosis and treatment aim to restore normal eating patterns and improve daily functioning rather than extend life expectancy, which is not reduced by the disease.

Did you know?

  1. The esophagus normally contains absolutely no eosinophils—finding even a few under the microscope is abnormal, but 15 or more per high-power field indicates eosinophilic esophagitis.
  2. Eosinophilic esophagitis was only identified as a distinct disease in the early 1990s, making it one of the newest recognized chronic conditions affecting the digestive system.
  3. About 70% of healthcare decisions depend on diagnostic test results, yet only 3-5% of healthcare budgets typically go toward diagnostic services, highlighting their undervalued but critical role.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.